{
    "code": "01R00024",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01R00024",
    "time": "2016-11-18 16:03:20",
    "許可證字號": "衛署藥製字第R00024號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/05\/26",
    "發證日期": "94\/05\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY001R0002402",
    "中文品名": "核研銦-111胜太銦腫瘤注射劑",
    "英文品名": "INER IN-111-PENTETREOTIDE INJECTION",
    "適應症": "適用於具有體抑素 SOMATOSTATIN 接受器之原位及轉移性神經內分泌瘤定位造影診斷。",
    "劑型": "270注射劑",
    "包裝": "盒裝 小瓶",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "PENTETREOTIDE,INDIUMIN-111CHLORIDE"
    ],
    "限制項目": "01國　產 54依本署89、12、12衛署藥字第0890035812號公告事項九得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "0613004200  行政院原子能委員會核能研究所",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0613004300  行政院原子能委員會核能研究所",
        "製造廠廠址": "桃園市龍潭區佳安村文化路１０００號",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30063000002 Ｘ光檢驗用不透光製劑；專供病人用之診斷用試藥Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6400001230",
            "成分名稱": "PENTETREOTIDE",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "UG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "7804001410",
            "成分名稱": "INDIUM IN-111 CHLORIDE",
            "含量描述": "(111 MBq\/mL)",
            "含量": "1.1000000000",
            "單位": "ML"
        }
    ],
    "仿單外盒": [
        {
            "title": "3.Pentetreotide盒標-104-10-14.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01R00024&Seq=002&Type=8"
        },
        {
            "title": "3.In-111瓶標-104-10-14.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01R00024&Seq=001&Type=8"
        }
    ]
}